An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials
Nat Med
.
2022 Sep;28(9):1740-1743.
doi: 10.1038/s41591-022-01989-8.
Authors
Sally Hopewell
1
,
Isabelle Boutron
2
3
,
An-Wen Chan
4
,
Gary S Collins
5
,
Jennifer A de Beyer
5
,
Asbjørn Hróbjartsson
6
7
,
Camilla Hansen Nejstgaard
6
7
,
Lasse Østengaard
6
7
,
Kenneth F Schulz
8
,
Ruth Tunn
9
,
David Moher
10
Affiliations
1
Oxford Clinical Trials Research Unit / Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
[email protected]
.
2
Université Paris Cité, Inserm, INRAE, Centre de Recherche Epidémiologie et Statistiques, Université Paris Cité, Paris, France.
3
Centre d'Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu, Paris, France.
4
Department of Medicine, Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
5
UK EQUATOR Centre/Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
6
Centre for Evidence-Based Medicine Odense and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
7
Open Patient Data Explorative Network, Odense University Hospital, Odense, Denmark.
8
Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
9
Oxford Clinical Trials Research Unit / Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
10
Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
PMID:
36109642
DOI:
10.1038/s41591-022-01989-8
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Checklist
Publishing*
Randomized Controlled Trials as Topic
Research Design*
Grants and funding
27294/CRUK_/Cancer Research UK/United Kingdom
C49297/A29084/CRUK_/Cancer Research UK/United Kingdom
DH_/Department of Health/United Kingdom
MR/W020483/1/MRC_/Medical Research Council/United Kingdom